Emphasize Daily Adherence With the New Oral Anticoagulants After Cardioversion

December 2014

You'll see the new oral anticoagulants (Pradaxa, Xarelto, Eliquis) used in patients with new onset atrial fib undergoing cardioversion.

We know that cardioversion sometimes converts patients back to normal heart rhythm. But it increases the risk of stroke...if an atrial clot is dislodged during the procedure.

That's why anticoagulants are usually given for at least 3 weeks in therapeutic doses before cardioversion...to stabilize clots and decrease the risk of embolism.

Get concise advice on drug therapy, plus unlimited access to CE

Pharmacist's Letter includes:

12 issues every year, with brief articles about new meds and hot topics
200+ CE courses, including the popular CE-in-the-Letter
Quick reference drug comparison charts
Access to the entire archive

Subscribe Today!

Already a subscriber? Log in

Volume pricing available. Get a quote

Asthma Use the "Rule of Two" to Help Improve Asthma Care
Opioids Suggest an NSAID Instead of Opioids for Chronic Musculoskeletal Pain
Women's Health Explain IUDs are Covered Under the Affordable Care Act
Diabetes Consider GLP-1 Agonists...Including New Trulicity...as Metformin Add-Ons
Diabetes Remind Patients to Gently Mix "Cloudy" Insulins...Even in Pens
Corticosteroids Advise Patients to Report Psychiatric Effects With Steroids
Hepatitis C Watch for Acid-Reducer Interactions With New Hep C Med Harvoni
Influenza Save Flu Antivirals for Severely Ill or High-Risk Patients
Wound Care Don't Assume Expensive Wound Dressings Work Better
Antiemetics Reassure Chemo Patients That Oral Antiemetics Work Well
Controlled Substances Explain That Partial Fills of Controlled Meds Aren't Considered Refills
Infection Control Use Soap and Water After C. Difficile or Norovirus Exposure
Antithrombotics Emphasize Daily Adherence With the New Oral Anticoagulants After Cardioversion

Emphasize Daily Adherence With the New Oral Anticoagulants After Cardioversion

Get concise advice on drug therapy, plus unlimited access to CE

Table of Contents